CXCR5 engineered human and murine Tregs for targeted suppression in secondary and tertiary lymphoid organs. - Doglio M; Rana J; Stucchi A; Melero MM; Ugolini A; Jofra T; Toma C; Bercher-Brayer C; Carulli P; Kumar S; Monti P; Martini E; et al. (Frontiers in immunology, 2025)